Goldman P - Search Results

1

Do medical devices have enhanced placebo effects?

Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Kaptchuk TJ, et al. Among authors: goldman p. J Clin Epidemiol. 2000 Aug;53(8):786-92. doi: 10.1016/s0895-4356(00)00206-7. J Clin Epidemiol. 2000. PMID: 10942860 Review.

2

Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome.

Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE, Kirsch I, Schyner RN, Nam BH, Nguyen LT, Park M, Rivers AL, McManus C, Kokkotou E, Drossman DA, Goldman P, Lembo AJ. Kaptchuk TJ, et al. Among authors: goldman p. BMJ. 2008 May 3;336(7651):999-1003. doi: 10.1136/bmj.39524.439618.25. Epub 2008 Apr 3. BMJ. 2008. PMID: 18390493 Free PMC article. Clinical Trial.

3

The powerful placebo: doubting the doubters.

Greene PJ, Wayne PM, Kerr CE, Weiger WA, Jacobson E, Goldman P, Kaptchuk TJ. Greene PJ, et al. Among authors: goldman p. Adv Mind Body Med. 2001 Fall;17(4):298-307; discussion 312-8. Adv Mind Body Med. 2001. PMID: 11931055 Review. No abstract available.

4

Herbal medicines today and the roots of modern pharmacology.

Goldman P. Goldman P. Ann Intern Med. 2001 Oct 16;135(8 Pt 1):594-600. doi: 10.7326/0003-4819-135-8_part_1-200110160-00010. Ann Intern Med. 2001. PMID: 11601931 Review.

5

Olestra: assessing its potential to interact with drugs in the gastrointestinal tract.

Goldman P. Goldman P. Clin Pharmacol Ther. 1997 Jun;61(6):613-8. doi: 10.1016/S0009-9236(97)90094-1. Clin Pharmacol Ther. 1997. PMID: 9209243 Review. No abstract available.

6

Ginkgo biloba does not alter clearance of flurbiprofen, a cytochrome P450-2C9 substrate.

Greenblatt DJ, von Moltke LL, Luo Y, Perloff ES, Horan KA, Bruce A, Reynolds RC, Harmatz JS, Avula B, Khan IA, Goldman P. Greenblatt DJ, et al. Among authors: goldman p. J Clin Pharmacol. 2006 Feb;46(2):214-21. doi: 10.1177/0091270005283465. J Clin Pharmacol. 2006. PMID: 16432273 Clinical Trial.

7

Urinary organic acid profiles in obese (ob/ob) mice: indications for the impaired omega-oxidation of fatty acids.

Lai RK, Goldman P. Lai RK, et al. Among authors: goldman p. Metabolism. 1992 Jan;41(1):97-105. doi: 10.1016/0026-0495(92)90197-i. Metabolism. 1992. PMID: 1538648

8

Organic acid profiling in adipocyte differentiation of 3T3-F442A cells: increased production of Krebs cycle acid metabolites.

Lai RK, Goldman P. Lai RK, et al. Among authors: goldman p. Metabolism. 1992 May;41(5):545-7. doi: 10.1016/0026-0495(92)90216-w. Metabolism. 1992. PMID: 1588836

9

Urinary organic acid profiles in fatty Zucker rats: indications for impaired oxidation of butyrate and hexanoate.

McDevitt J, Wilson S, Her GR, Stobiecki M, Goldman P. McDevitt J, et al. Among authors: goldman p. Metabolism. 1990 Oct;39(10):1012-20. doi: 10.1016/0026-0495(90)90159-a. Metabolism. 1990. PMID: 2215249

10

Biologically active secondary metabolites from Ginkgo biloba.

Bedir E, Tatli II, Khan RA, Zhao J, Takamatsu S, Walker LA, Goldman P, Khan IA. Bedir E, et al. Among authors: goldman p. J Agric Food Chem. 2002 May 22;50(11):3150-5. doi: 10.1021/jf011682s. J Agric Food Chem. 2002. PMID: 12009978

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

317 results

Search Page